Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants
about
SORL1 variants and risk of late-onset Alzheimer's diseaseEvidence for an association between KIBRA and late-onset Alzheimer's diseaseGenome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's diseaseAssessment of Alzheimer's disease case-control associations using family-based methodsInvestigation of 15 of the top candidate genes for late-onset Alzheimer's diseaseGenetics of late-onset Alzheimer's disease: update from the alzgene database and analysis of shared pathwaysTranscriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's diseaseAssociation studies of 22 candidate SNPs with late-onset Alzheimer's diseaseGenetic variants identified in a European genome-wide association study that were found to predict incident coronary heart disease in the atherosclerosis risk in communities studyGenome-wide association studies in Alzheimer's diseaseEndophenotypes in normal brain morphology and Alzheimer's disease: a reviewSumoylation in Synaptic Function and DysfunctionThe sodium leak channel, NALCN, in health and diseaseThe genetics and neuropathology of Alzheimer's diseaseMeta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's diseaseIntermediate phenotypes identify divergent pathways to Alzheimer's diseaseDementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalitiesGenome-wide association study of Alzheimer's diseaseGenomic variants, genes, and pathways of Alzheimer's disease: An overview.Association of CLU and PICALM variants with Alzheimer's disease.Evidence for three loci modifying age-at-onset of Alzheimer's disease in early-onset PSEN2 families.Genome scan of age-at-onset in the NIMH Alzheimer disease sample uncovers multiple loci, along with evidence of both genetic and sample heterogeneity.Further analysis of previously implicated linkage regions for Alzheimer's disease in affected relative pairs.The Rare-Variant Generalized Disequilibrium Test for Association Analysis of Nuclear and Extended Pedigrees with Application to Alzheimer Disease WGS Data.A large-scale rheumatoid arthritis genetic study identifies association at chromosome 9q33.2.Assessing batch effects of genotype calling algorithm BRLMM for the Affymetrix GeneChip Human Mapping 500 K array set using 270 HapMap samples.Use of genetic variation as biomarkers for Alzheimer's disease.Gene expression levels as endophenotypes in genome-wide association studies of Alzheimer diseaseGenome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.Late onset Alzheimer's disease genetics implicates microglial pathways in disease risk.GAB2 as an Alzheimer disease susceptibility gene: follow-up of genomewide association resultsClinical genetics of Alzheimer's diseaseIdentification of novel candidate genes for Alzheimer's disease by autozygosity mapping using genome wide SNP dataA putative Alzheimer's disease risk allele in PCK1 influences brain atrophy in multiple sclerosis.Genome-wide association studies: progress and potential for drug discovery and development.Alzheimer's disease: insights from Drosophila melanogaster models.Recent insights into the molecular genetics of dementiaGenome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOEGenetics of Alzheimer disease in the pre- and post-GWAS eraGenetic variation at a single locus and age of onset for Alzheimer's disease.
P2860
Q24289419-57A55190-223B-4FE3-884E-5B352260B9D6Q24598464-A2EEDE2B-233F-4E1C-B90C-7FC5F0CD56A8Q24612662-56FBAFA0-33F5-4D68-94BA-964A9FFBBCEFQ24622654-31380296-3D53-4327-8E8A-65CF4E369B5DQ24628049-E0B6B4D2-C63A-4060-9514-ED3C8785ADF4Q24629875-40E97765-FDF4-4281-B268-CA7EFEB460FDQ24631387-A5DE4BF8-4CF3-4B6A-800B-BDF27A857F02Q24647572-FA6456C8-F39D-49C5-833D-828F5435B39EQ24651685-82484B79-3584-44E6-A48A-B8AB8DB498AAQ24655873-8954DC31-E9B7-4BD3-B471-9FE90DBC80D0Q24655973-BD8FB5AF-A908-412F-8DFB-C64E3716C962Q26747536-F4CB3D4C-C20D-489D-9925-7BAE28E8CA86Q26851725-1739E8F7-F9A3-4901-B16C-956049F59332Q26998097-F607B3A0-E675-4423-AE9D-EEBA47122B49Q28742427-F517A38F-5F91-4328-8447-5919D0DAA9C3Q28751409-9DD5EC02-6E86-46F8-8FB6-768F7E0CD4FFQ28943531-A796F2E0-D688-4669-8828-9AFDAA32ACA1Q29417071-078DC424-AF01-4396-AE3A-94C9FDA28A50Q30240093-21775EE0-2EA5-4EDA-A1E7-9E204F3454DDQ30422270-81FA0AEB-D107-4421-9065-01C4E8EE0FCCQ30497920-89F9F4A1-EE6B-4BC3-A221-34DE9B6B2FDEQ30503996-4567477D-1344-456E-B823-641F4E66D93AQ30936616-72166E62-4DA8-412A-B547-ECD398B0B8F2Q31153544-CC1CCFC2-84D6-49F7-B4BC-4684B6FF6526Q33354118-B5A098AB-F7FD-4723-AA7D-0988B829F9A3Q33369610-3D1D0A68-1C2F-4FF9-B4D1-248E23173F0EQ33640956-B1EDE35F-05A1-4D04-9E91-A6D9A632F52DQ33698166-8327A640-8E68-4962-B44A-632E4FE4A058Q33713286-82B160C0-1A00-45CC-ADD1-57996079A864Q33733863-AA8302DF-470B-4F44-8D3A-0A50206225A0Q33737133-C9101378-8109-48E3-AC31-D562B894535FQ33737786-73B54ADC-C24E-497E-922E-57F158C93F88Q33753746-DC6D1A2B-5C03-47E3-8B55-1BAA716F0A54Q33769940-2C2AAA45-2460-47BF-A0BF-57BD259E8ADBQ33784699-537DF29C-D666-4007-A988-EAD693C10505Q33799241-A1B0459A-B2F9-4BB2-9967-6CA96E4C33FDQ33830518-89342E34-B07D-4EC0-8CDB-C246514513E0Q33838241-D3CB34FD-8FAA-4592-967F-512E0B760F19Q33867876-7317149F-420C-4EF4-9A91-35B03058984FQ33870512-7607AB45-8615-4DD0-9F15-C691C9D8DE92
P2860
Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants
description
article
@en
im Februar 2007 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2007
@uk
name
Evidence for novel susceptibil ...... f putative functional variants
@en
Evidence for novel susceptibil ...... f putative functional variants
@nl
type
label
Evidence for novel susceptibil ...... f putative functional variants
@en
Evidence for novel susceptibil ...... f putative functional variants
@nl
prefLabel
Evidence for novel susceptibil ...... f putative functional variants
@en
Evidence for novel susceptibil ...... f putative functional variants
@nl
P2093
P2860
P50
P356
P1476
Evidence for novel susceptibil ...... f putative functional variants
@en
P2093
Andrew Grupe
Angharad Morgan
Brian Lawlor
Charles Rowland
David Rubinsztein
David Stone
Eric Schadt
John C. Morris
John Sninsky
Joseph Catanese
P2860
P304
P356
10.1093/HMG/DDM031
P50
P577
2007-02-22T00:00:00Z